The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 19.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 42% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 107%. Our forward projection puts the odds of a 10% gain over the next month near 43%. The street (4 analysts) rates it none, with a mean price target of $6.
Butterfly Network, Inc. BFLY
Outside both standards
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Butterfly Network, Inc.
read at $9.45
Butterfly Network, Inc. holds its Markup at $9.45.
- PHPhase · the trend structure carries the Markup label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · does not pass the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 17 days |
| Price | $9.45 |
| Valuation | N/A trailing · -157.50 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 2.08 |
The opportunity · what the numbers say it is worth
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Both our model and the analysts see meaningful upside from here.
| Revenue growth | 39.50% |
| Profit margin | -66.75% |
| Debt to equity | 10.08 |
| Analyst consensus | Strong Buy · 4 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company is excluded by both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. It fails on both:
Used by most halal investing apps ✗ DOES NOT PASS
The one Titan applies ✗ DOES NOT PASS
Why it fails. The problem is its accounts receivable. Because both standards agree on this, it is a clear exclusion, not a borderline case.
What these two standards are, and how they differ →
- Business activity Its core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
- Debt load Interest-bearing debt is just 6.9% of its assets, well under the one-third ceiling — it does not run on borrowed money. Pass
- Interest-bearing cash Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
- Receivables Money owed to the company is 59.8% of assets, above the 49% limit. Fail
- Revenue purity 6.1% of revenue comes from non-compliant sources, over the 5% line. Fail
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Handheld Scanner Promise Collides With Heavy Losses
A doctor in a remote clinic reaches for a probe the size of a smartphone rather than wheeling out a bulky machine. Butterfly Network built exactly that device and revenue is rising twenty five percent, yet the business still posts a seventy four percent negative profit margin and negative thirty five percent return on equity. The shares sit above our fair value with no margin of safety and a deeply negative forward earnings multiple.
Growth in portable ultrasound looks attractive on paper but four analysts see no consensus upside and the company has yet to prove it can convert device sales into sustainable profits. Unknown competitive position and execution risk on scaling leave the investment case thin despite the ethical screen clearing cleanly.
High cash burn and uncertain hospital adoption keep the risk profile elevated. The setup offers little reason to get involved at current levels.
Analysis, not advice.
| Forward P/E | -157.5x |
| Revenue growth | 39.5% strong top-line growth |
| Profit margin | -66.7% currently unprofitable |
| Return on equity | -35.5% not currently earning a positive return on equity |
| Debt to equity | 0.10 minimal debt — a conservative balance sheet |
| Current ratio | 4.06 comfortably covers its short-term bills |
| Beta | 2.08 much more volatile than the market |
| Market cap | $2.5B |
| Employees | 220 |
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Related securities · others in BFLY's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
BFLY trades on the NYSE. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 42% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 107%. Our forward projection puts the odds of a 10% gain over the next month near 43%. The street (4 analysts) rates it none, with a mean price target of $6.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $4.20 | +28.7% | · | $1,287 | +28.7% |
| 2 months | $4.11 | +31.5% | · | $1,315 | +31.5% |
| 3 months | $3.64 | +48.5% | · | $1,485 | +48.5% |
| 6 months | $3.08 | +75.5% | · | $1,755 | +75.5% |
| 1 year | $2.61 | +107.1% | · | $2,071 | +107.1% |
| 2 years | $0.95 | +469.0% | · | $5,690 | +469.0% |
| 3 years | $2.17 | +149.1% | · | $2,491 | +149.1% |
| 5 years | $14.11 | -61.7% | · | $383 | -61.7% |
Historical returns from market close data. Past performance does not guarantee future results.